Tacconelli, Evelina
 Distribuzione geografica
Continente #
NA - Nord America 4.496
EU - Europa 2.616
AS - Asia 2.443
SA - Sud America 430
Continente sconosciuto - Info sul continente non disponibili 97
AF - Africa 57
OC - Oceania 13
Totale 10.152
Nazione #
US - Stati Uniti d'America 4.385
SG - Singapore 1.091
CN - Cina 696
DE - Germania 690
SE - Svezia 430
IT - Italia 406
BR - Brasile 350
UA - Ucraina 261
FR - Francia 247
VN - Vietnam 178
GB - Regno Unito 132
IE - Irlanda 99
TR - Turchia 87
PL - Polonia 81
FI - Finlandia 78
ID - Indonesia 73
IN - India 63
JP - Giappone 60
CA - Canada 55
RU - Federazione Russa 54
BD - Bangladesh 45
HK - Hong Kong 44
AR - Argentina 31
NL - Olanda 29
ES - Italia 18
BE - Belgio 17
IQ - Iraq 17
ZA - Sudafrica 17
MX - Messico 15
PK - Pakistan 15
VE - Venezuela 12
EC - Ecuador 11
MA - Marocco 11
AU - Australia 10
AT - Austria 9
CH - Svizzera 8
CO - Colombia 8
IR - Iran 8
PT - Portogallo 8
EG - Egitto 7
KE - Kenya 7
SA - Arabia Saudita 7
BZ - Belize 6
GR - Grecia 6
HN - Honduras 6
JM - Giamaica 6
JO - Giordania 6
LT - Lituania 6
RO - Romania 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
BS - Bahamas 5
KR - Corea 5
PE - Perù 5
PH - Filippine 5
TN - Tunisia 5
AZ - Azerbaigian 4
CL - Cile 4
CZ - Repubblica Ceca 4
NP - Nepal 4
OM - Oman 4
PA - Panama 4
TH - Thailandia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BY - Bielorussia 3
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
LV - Lettonia 3
MY - Malesia 3
NG - Nigeria 3
RS - Serbia 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
IL - Israele 2
LB - Libano 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
AI - Anguilla 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 10.049
Città #
Chandler 582
Singapore 581
Ashburn 391
San Jose 289
Jacksonville 181
Beijing 115
San Mateo 110
Nanjing 98
Dublin 94
Ann Arbor 85
Woodbridge 75
Dearborn 73
Jakarta 68
Izmir 65
Marseille 65
Hefei 64
Los Angeles 64
Houston 55
Lauterbourg 54
Wilmington 54
Ho Chi Minh City 50
New York 50
Tokyo 50
Frankfurt am Main 49
Boston 47
Chicago 45
Milan 45
Hanoi 43
Warsaw 39
Lancaster 38
Kraków 37
Dallas 34
Hong Kong 34
Nürnberg 34
Lawrence 30
Munich 30
Nanchang 30
Princeton 30
Seattle 30
São Paulo 29
Philadelphia 28
Buffalo 27
Rome 27
Shenyang 27
Kunming 26
Redwood City 26
Brooklyn 25
Moscow 25
Santa Clara 24
Fairfield 22
Bremen 21
Mountain View 21
Tianjin 21
Boardman 19
San Francisco 19
Shanghai 19
Verona 19
Naples 18
Norwalk 18
Phoenix 18
The Bronx 18
The Dalles 18
Atlanta 17
Changsha 17
Helsinki 17
Jiaxing 17
Brussels 16
Hangzhou 16
Hebei 16
Washington 16
Guangzhou 15
University Park 15
Kent 14
Memphis 14
Zhengzhou 14
Fremont 13
London 13
Quattro Castella 13
Queens 13
Belo Horizonte 12
Cleveland 12
Leawood 12
Johannesburg 11
Orem 11
Rio de Janeiro 11
Cattolica 10
Council Bluffs 10
Da Nang 10
Montreal 10
Ningbo 10
Nuremberg 10
Renton 10
Delhi 9
Jinan 9
Miami 9
Augusta 8
Columbus 8
Las Vegas 8
Newark 8
Pittsburgh 8
Totale 4.885
Nome #
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli 841
Outbreak of Saprochaete clavata Sepsis in Hematology Patients: Combined Use of MALDI-TOF and Sequencing Strategy to Identify and Correlate the Episodes 398
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 354
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 211
In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli 206
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis 201
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 197
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 196
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 182
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 180
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 178
Vancomycin-resistant enterococci (VRE): transmission and control 176
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 174
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 174
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 172
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma 171
Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. 168
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 166
EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach 163
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis 162
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients, a systematic review and meta-analysis 161
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 156
HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy 154
STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship 153
Correlation between cidofovir-associated uveitis and failing immunorestoration during HAART. 149
Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study 149
Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis 147
Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. 147
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 144
Bacterial pneumonia in HIV-infected patients. Analysis of risk factors and prognostic indicators 143
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. 143
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 141
Meningoencephalomyelitis caused by herpes simplex virus-1 in a patient with idiopathic T CD4+ lymphocytopenia. 140
How could we reduce antibiotic use in critically ill patients? 139
Nosocomial Bloodstream infections in HIV-infected patients: attributable mortality and eccess of hospital stay. 139
Older HIV-positive patients in the era of highly active antiretroviral therapy: changing a scenario 138
Phemphigus vulgaris in a human-immunodeficiency-virus-infected patient. 137
Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy. 135
HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era 131
Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals. 131
A large survey among European trainees in clinical microbiology and infectious disease on training systems and training adequacy: identifying the gaps and suggesting improvements 127
Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study 127
Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues 126
ESCMID-EUCIC clinical guidelines on decolonisation of multidrug-resistant Gram-negative bacteria carriers 126
Effect of Highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV infected subjects 124
Topical negative pressure to treat surgical site infections, with a focus on post-sternotomy infections: a systematic review and meta-analysis 123
Personal life and working conditions of trainees and young specialists in clinical microbiology and infectious diseases in Europe: a questionnaire survey 119
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks 119
Candidemia in HIV infected subjects 116
Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010 115
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 113
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: A multicentre retrospective cohort study 113
Methicillin-resistant Staphylococcus aureus: source control and surveillance organization. 109
National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the Netherlands. 108
Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. 108
Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. 107
Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study 100
Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings 98
Risk Factors and prognostic indicators of bacterial meningitis in a cohort of 3580 postneurosurgical patients 96
ESCMID - an international Europe-based society committed to fostering cross-border collaboration and education to improve patient care 89
ESCMID white paper: a guide on ESCMID guidance documents 88
Methicillin-resistant Staphylococcus aureus: risk assessment and infection control policies 87
The management of methicillin-resistant Staphylococcus aureus infection in Europe. 86
Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study 81
Totale 10.152
Categoria #
all - tutte 36.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.102


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022565 0 48 19 36 14 16 13 94 24 40 90 171
2022/20231.477 203 216 167 196 91 148 100 119 149 14 44 30
2023/2024501 37 178 8 47 14 29 20 32 10 24 46 56
2024/20251.114 33 48 73 48 90 32 40 72 211 76 206 185
2025/20263.591 409 108 150 251 502 164 558 135 205 199 834 76
2026/2027364 139 225 0 0 0 0 0 0 0 0 0 0
Totale 10.152